Completed PHASE3 INTERVENTIONAL NCT00004286

Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

Sponsor: National Center for Research Resources (NCRR)

Conditions Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Feb 29, 1996 Completion: Nov 30, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00004286, this PHASE3 trial focuses on Polyradiculoneuropathy, Chronic Inflammatory Demyelinating and remains completed. Sponsored by National Center for Research Resources (NCRR), it has been updated 5 times since 1996, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 1996

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Research Resources (NCRR)
University of Vermont

Data source: Office of Rare Diseases (ORD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.